Book contents
- Frontmatter
- Contents
- List of contributors
- Preface
- Part I Introduction: definition and classification of the human herpesviruses
- Part II Basic virology and viral gene effects on host cell functions: alphaherpesviruses
- Part II Basic virology and viral gene effects on host cell functions: betaherpesviruses
- Part II Basic virology and viral gene effects on host cell functions: gammaherpesviruses
- Part III Pathogenesis, clinical disease, host response, and epidemiology: HSV-1 and HSV-2
- Part III Pathogenesis, clinical disease, host response, and epidemiology: VZU
- 37 VZV: pathogenesis and the disease consequences of primary infection
- 38 VZV: molecular basis of persistence (latency and reactivation)
- 39 VZV: immunobiology and host response
- 40 VZV: persistence in the population: transmission and epidemiology
- Part III Pathogenesis, clinical disease, host response, and epidemiology: HCMV
- Part III Pathogenesis, clinical disease, host response, and epidemiology: HHV- 6A, 6B, and 7
- Part III Pathogenesis, clinical disease, host response, and epidemiology: gammaherpesviruses
- Part IV Non-human primate herpesviruses
- Part V Subversion of adaptive immunity
- Part VI Antiviral therapy
- Part VII Vaccines and immunothgerapy
- Part VIII Herpes as therapeutic agents
- Index
- Plate section
- References
38 - VZV: molecular basis of persistence (latency and reactivation)
from Part III - Pathogenesis, clinical disease, host response, and epidemiology: VZU
Published online by Cambridge University Press: 24 December 2009
- Frontmatter
- Contents
- List of contributors
- Preface
- Part I Introduction: definition and classification of the human herpesviruses
- Part II Basic virology and viral gene effects on host cell functions: alphaherpesviruses
- Part II Basic virology and viral gene effects on host cell functions: betaherpesviruses
- Part II Basic virology and viral gene effects on host cell functions: gammaherpesviruses
- Part III Pathogenesis, clinical disease, host response, and epidemiology: HSV-1 and HSV-2
- Part III Pathogenesis, clinical disease, host response, and epidemiology: VZU
- 37 VZV: pathogenesis and the disease consequences of primary infection
- 38 VZV: molecular basis of persistence (latency and reactivation)
- 39 VZV: immunobiology and host response
- 40 VZV: persistence in the population: transmission and epidemiology
- Part III Pathogenesis, clinical disease, host response, and epidemiology: HCMV
- Part III Pathogenesis, clinical disease, host response, and epidemiology: HHV- 6A, 6B, and 7
- Part III Pathogenesis, clinical disease, host response, and epidemiology: gammaherpesviruses
- Part IV Non-human primate herpesviruses
- Part V Subversion of adaptive immunity
- Part VI Antiviral therapy
- Part VII Vaccines and immunothgerapy
- Part VIII Herpes as therapeutic agents
- Index
- Plate section
- References
Summary
Primary infection with varicella-zoster virus (VZV) causes varicella manifested by fever and a vesicular rash. During primary infection the virus disseminates in lymphocytes to the skin and other organs, and replicates in and establishes a latent infection in the nervous system (Croen et al., 1988). Early studies demonstrated viral DNA in human trigeminal and dorsal root ganglia by in situ hybridization and Southern blotting (Gilden et al., 1983, 1987; Hyman et al., 1983). More recent studies, using PCR, have demonstrated latent VZV in multiple cranial nerve, dorsal root, and autonomic ganglia (Furuta et al., 1992, 1997; Gilden et al., 2001; Mahalingham et al., 1990). The virus can reactivate from these sites to cause herpes zoster.
The structure of the VZV genome during latency is not certain. Clarke et al. (1995) performed PCR on human ganglia DNA using pairs of primers specific for the unique long internal and terminal regions of the genome. Analysis of the ratio of the signals of the PCR products indicated that the termini of the genome are adjacent during latency, suggesting that the VZV genome is probably episomal.
Site of VZV latency
A number of studies have attempted to identify the cell type in which VZV is latent in human ganglia (Table 38.1). While early studies using in situ hybridization suggested that the virus was present in neurons (Hyman et al., 1983; Gilden et al., 1987), other studies suggested that viral RNA was latent exclusively in satellite cells that surround the neurons (Croen et al., 1988).
- Type
- Chapter
- Information
- Human HerpesvirusesBiology, Therapy, and Immunoprophylaxis, pp. 689 - 699Publisher: Cambridge University PressPrint publication year: 2007
References
- 6
- Cited by